Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (521-530 of 567) with videos related to

Pageof 57
Sort By:
Pharmacogenetics and Genomics|September 16, 2009
Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective studyAndrea L Jorgensen, Sameh Al-Zubiedi, Jieying Eunice Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid LeukemiaMithun Vinod Shah, Jeffrey L Jorgensen, Rima M Saliba, et al.
The Lancet. Oncology|August 25, 2014
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 studyJan A Burger, Michael J Keating, William G Wierda, et al.
Haematologica|September 2, 2018
Persistent <i>IDH1/2</i> mutations in remission can predict relapse in patients with acute myeloid leukemiaChi Young Ok, Sanam Loghavi, Dawen Sui, et al.
The Lancet. Respiratory Medicine|March 20, 2018
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association studyDaniel B Hawcutt, Ben Francis, Daniel F Carr, et al.
Communications Biology|January 18, 2023
A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomicsChia-Feng Tsai, Yi-Ting Wang, Chuan-Chih Hsu, et al.
British Journal of Haematology|February 22, 2021
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemiaSanam Loghavi, Courtney D DiNardo, Ken Furudate, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
Human Pathology|March 22, 2016
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patientsMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Pageof 57

Showing results (521-530 of 567) with videos related to

Sort By:
Pageof 57
Pharmacogenetics and Genomics|September 16, 2009
Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective studyAndrea L Jorgensen, Sameh Al-Zubiedi, Jieying Eunice Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid LeukemiaMithun Vinod Shah, Jeffrey L Jorgensen, Rima M Saliba, et al.
The Lancet. Oncology|August 25, 2014
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 studyJan A Burger, Michael J Keating, William G Wierda, et al.
Haematologica|September 2, 2018
Persistent <i>IDH1/2</i> mutations in remission can predict relapse in patients with acute myeloid leukemiaChi Young Ok, Sanam Loghavi, Dawen Sui, et al.
The Lancet. Respiratory Medicine|March 20, 2018
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association studyDaniel B Hawcutt, Ben Francis, Daniel F Carr, et al.
Communications Biology|January 18, 2023
A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomicsChia-Feng Tsai, Yi-Ting Wang, Chuan-Chih Hsu, et al.
British Journal of Haematology|February 22, 2021
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemiaSanam Loghavi, Courtney D DiNardo, Ken Furudate, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
Human Pathology|March 22, 2016
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patientsMariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Pageof 57